基因甲基化通过甲基-CpG结合蛋白间接抑制转录
Cell
|March 22, 1991
概括
基因甲基化通过甲基-CpG结合蛋白 (MeCP-1) 间接抑制基因转录. 这种机制在无细胞系统和活细胞中得到证实,MeCP-1缺乏的细胞显示抑制减少.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因规则 基因规则
背景情况:
- 基因甲基化是影响基因表达的关键表观遗传机制.
- 了解DNA甲基化如何抑制转录对于理解细胞功能和疾病至关重要.
- 之前对甲基-CpG结合蛋白 (MeCPs) 的鉴定表明它们在调解基于甲基化的抑制中的作用.
研究的目的:
- 阐明DNA甲基化抑制转录的机制.
- 要确定这种镇压是直接还是间接发生的.
- 研究甲基-CpG结合蛋白在这种过程中在无细胞提取物和活细胞中的作用.
主要方法:
- 在体外转录试验中,使用含有甲基化和非甲基化促进剂的无细胞核提取物进行了转录试验.
- 从核提取物中分离出来的抑制活性的表征.
- 在活细胞中使用差异甲基化促进剂和竞争剂进行过渡性转染试验.
- 在MeCP-1缺陷细胞中对基因抑制的分析.
主要成果:
- 通过DNA甲基化介导的转录抑制被发现是体外间接效应.
- 已识别的抑制媒介表现出与甲基-CpG结合蛋白1 (MeCP-1) 相同的特性.
- 过渡性转染试验表明,通过MeCP-1的间接抑制发生在活细胞中.
- 缺乏MeCP-1的细胞显著减少了甲基化基因的抑制.
结论:
- 基因甲基化通过甲基-CpG结合蛋白1 (MeCP-1) 的作用间接抑制转录.
- MeCP-1 是通过DNA甲基化进行转录抑制的关键媒介,在无细胞系统和活细胞中.
- 这些发现突显了MeCP-1在表观遗传基因沉默中的关键作用.
更多相关视频
10:09Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
6.8K
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.5K
相关概念视频
Epigenetic Regulation
28.7K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
Histone Modification
14.6K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
14.6K
RNA Polymerase II Accessory Proteins
8.9K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
8.9K
Eukaryotic Transcription Inhibitors
9.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.1K
Master Transcription Regulators
6.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K
Epigenetic Regulation
3.5K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.5K
